Clinical Trials Directory

Trials / Completed

CompletedNCT01242618

Tissue Engineered Nasal Cartilage for Reconstruction of the Alar Lobule

Tissue Engineered Nasal Cartilage for Reconstruction of the Alar Lobule Following Resection of a Non Melanoma Skin Cancer- a Phase I Clinical Trial.

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
5 (actual)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the safety and feasibility of implanting an engineered cartilage graft, obtained by culturing expanded autologous nasal chondrocytes within a collagen type I/III membrane, in the alar lobule of patients after resection of a non melanoma skin cancer.

Detailed description

Skin cancer is the most prevalent reason for surgically creating a multilayer defect, consisting of skin and cartilage, of the alar lobule of the nose. In reconstruction of these defects, a combination of local flaps and autologous cartilage, typically harvested from the nasal septum or the ear, is used to restore the stability, function and proper 3D shape of the alar lobule. Harvesting autologous cartilage from the ear has been associated with a number of complications that could be overcome by the use of engineered cartilage graft generated in vitro with autologous cells. This study is a phase I, prospective, uncontrolled, investigator initiated clinical trial involving 5 patients, with the objective of demonstrating safety and feasibility in the use of engineered nasal cartilage grafts. The specific surgical target of the trial is the reconstruction of a two layer defect of the alar lobule using a tissue engineered nasal cartilage graft and a local flap, following resection of a non melanoma skin cancer.

Conditions

Interventions

TypeNameDescription
BIOLOGICALengineered nasal cartilage graftimplantation of engineered nasal cartilage grafts in the alar lobule

Timeline

Start date
2010-10-01
Primary completion
2013-02-01
First posted
2010-11-17
Last updated
2014-08-20

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01242618. Inclusion in this directory is not an endorsement.